Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 5, 2021EMBO Molecular MedicineOpen Access

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau

View Full Paper
Ask AI
Bookmark
Share

Authors

NMNiklas MattssonUniversity of Southern CaliforniaSJShorena JanelidzeLund UniversityRBRandall J. BatemanUlsan College

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mattsson et al. (2021) studied this question.

synapsesocial.com/papers/69d90aa3f6b7aa27b79f55aehttps://doi.org/10.15252/emmm.202114022
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Predicting diagnosis and cognition with 18 F‐AV‐1451 tau PET and structural MRI in Alzheimer's disease2019 · 100 citations
  2. 2Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer’s disease2020 · 151 citations
  3. 3Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models2015 · 54 citations
  4. 4Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders2020 · 1,676 citations
  5. 5Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease1997 · 1,565 citations